146 related articles for article (PubMed ID: 38091807)
1. Expression analysis of Treg-related lncRNAs in neuromyelitis optica spectrum disorder.
Harsij A; Gharebaghi A; Ghiasian M; Eslami S; Ghafouri-Fard S; Taheri M; Sayad A
Mult Scler Relat Disord; 2024 Jan; 81():105350. PubMed ID: 38091807
[TBL] [Abstract][Full Text] [Related]
2. Expression of T cell-related lncRNAs in multiple sclerosis.
Dadyar M; Hussen BM; Eslami S; Taheri M; Emadi F; Ghafouri-Fard S; Sayad A
Front Genet; 2022; 13():967157. PubMed ID: 36092928
[TBL] [Abstract][Full Text] [Related]
3. Expression of Treg-associated lncRNAs in breast cancer.
Moallemi-Rad L; Ghorbani A; Dadyar M; Hussen BM; Rasul MF; Eslami S; Taheri M; Jamali E; Ghafouri-Fard S
Pathol Res Pract; 2023 Jan; 241():154270. PubMed ID: 36535227
[TBL] [Abstract][Full Text] [Related]
4. Analysis of expression of regulatory T cell related lncRNAs in inflammatory demyelinating polyneuropathies.
Taheri M; Roustapour S; Gholipour M; Hussen BM; Eslami S; Ghafouri-Fard S; Sayad A
Int Immunopharmacol; 2022 Nov; 112():109188. PubMed ID: 36041257
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Expression of Regulatory T Cell Differentiation Genes in Autism Spectrum Disorder.
Akbari M; Eghtedarian R; Hussen BM; Eslami S; Taheri M; Neishabouri SM; Ghafouri-Fard S
Front Mol Neurosci; 2022; 15():939224. PubMed ID: 35860502
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Treg-related lncRNAs in epilepsy.
Sharifi G; Eghtedarian R; Taheri M; Hussen BM; Eslami S; Ghafouri-Fard S; Sayad A
Front Mol Neurosci; 2022; 15():1031314. PubMed ID: 36776769
[TBL] [Abstract][Full Text] [Related]
7. Significant up-regulation of lncRNAs in neuromyelitis optica spectrum disorder.
Taheri M; Sadeghi A; Gharebaghi A; Ghiasian M; Eslami S; Khalilian S; Sayad A; Ghafouri-Fard S
Sci Rep; 2023 Oct; 13(1):18692. PubMed ID: 37907501
[TBL] [Abstract][Full Text] [Related]
8. Cytokines and chemokines in neuromyelitis optica: pathogenetic and therapeutic implications.
Uzawa A; Mori M; Kuwabara S
Brain Pathol; 2014 Jan; 24(1):67-73. PubMed ID: 24345220
[TBL] [Abstract][Full Text] [Related]
9. Clinical and radiological profile of neuromyelitis optica spectrum disorders in a Pakistani cohort.
Rajput HM; Hassan M; Badshah M
Mult Scler Relat Disord; 2023 Jun; 74():104656. PubMed ID: 37068371
[TBL] [Abstract][Full Text] [Related]
10. The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.
Cho EB; Cho HJ; Seok JM; Min JH; Kang ES; Kim BJ
Neurol Sci; 2018 Mar; 39(3):543-549. PubMed ID: 29349658
[TBL] [Abstract][Full Text] [Related]
11. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
Wu Y; Zhong L; Geng J
Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
[TBL] [Abstract][Full Text] [Related]
13. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
14. Foxp3+ regulatory T cells expression in neuromyelitis optica spectrum disorders.
Brill L; Lavon I; Vaknin-Dembinsky A
Mult Scler Relat Disord; 2019 May; 30():114-118. PubMed ID: 30771576
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
[TBL] [Abstract][Full Text] [Related]
16. Microarray Analysis of lncRNA and mRNA Expression Profiles in Patients with Neuromyelitis Optica.
Xu J; Zhang F; Gao C; Ma X; Peng X; Kong D; Hao J
Mol Neurobiol; 2017 Apr; 54(3):2201-2208. PubMed ID: 26941100
[TBL] [Abstract][Full Text] [Related]
17. Aquaporin-4 in Neuromyelitis Optica Spectrum Disorders: A Target of Autoimmunity in the Central Nervous System.
Abe Y; Yasui M
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454180
[TBL] [Abstract][Full Text] [Related]
18. Regulatory T cells protect against brain damage by alleviating inflammatory response in neuromyelitis optica spectrum disorder.
Ma X; Qin C; Chen M; Yu HH; Chu YH; Chen TJ; Bosco DB; Wu LJ; Bu BT; Wang W; Tian DS
J Neuroinflammation; 2021 Sep; 18(1):201. PubMed ID: 34526069
[TBL] [Abstract][Full Text] [Related]
19. Neuromyelitis optica spectrum disorder: do patients positive and negative for anti-aquaporin-4 antibodies present distinct entities? A Colombian perspective.
Ortiz Salas PA; Gaviria Carrillo M; Cortés Bernal GA; Moreno Medina K; Roa LF; Rodríguez Quintana JH
Neurologia (Engl Ed); 2023 Sep; 38(7):504-510. PubMed ID: 35637138
[TBL] [Abstract][Full Text] [Related]
20. Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis.
Bagherieh S; Afshari-Safavi A; Vaheb S; Kiani M; Ghaffary EM; Barzegar M; Shaygannejad V; Zabeti A; Mirmosayyeb O
Neurol Sci; 2023 Jun; 44(6):1905-1915. PubMed ID: 36745300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
